Novavax makes new appointment
This article was originally published in Scrip
Novavax (US) has appointed John Trizzino senior vice-president of international and government alliances. He has previously worked as vice-president of the vaccine franchise at MedImmune, senior vice-president of business development at ID Biomedical, vice-president in the Henry Schein medical division in business development and general manager of its GIV division.
You may also be interested in...
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.
Poseida, Nkarta and Inventiva raised $224m, $252m and $107.7m, respectively. Also, Forbion raised €185m ($208m) of a new €250m fund and Blackstone closed the last $1.2bn of its $4.6bn fund for public and private company deals, and Ascendis led recent follow-ons with a $569.2m offering.